hercul inc and collagen corp said form equal own joint ventur develop and market product for treatment dermal wound caus surgeri trauma diseas joint ventur will focus develop product heal dermal wound resist current avail treatment compani said said clinic studi will focus initi treat wound such decubitus ulcer bedsor caus prolong pressur and under diseas such diabet which compromis blood suppli reuter 